Covered recipient · General Payments record
ALEXIS CHARRIER WILLIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$316.29
- Reported across 13 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.29 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $40.92 | 1 |
| Janssen Biotech, Inc. | $39.73 | 2 |
| Genentech USA, Inc. | $32.27 | 1 |
| PharmaEssentia USA Corporation | $31.63 | 1 |
| Daiichi Sankyo Inc. | $26.87 | 1 |
| Merck Sharp & Dohme Corporation | $24.58 | 1 |
| SOBI, INC | $22.58 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.25 | 1 |
| Astellas Pharma US Inc | $20.18 | 1 |
| Exelixis Inc. | $19.74 | 1 |
| GlaxoSmithKline, LLC. | $19.55 | 1 |
| Surmodics, Inc. | $17.99 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $316.29 | 13 |
Payment records · PY2025 (13)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $40.92 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174645307 | CMS |
| Astellas Pharma US Inc | $20.18 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238759950 | CMS |
| Daiichi Sankyo Inc. | $26.87 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197096689 | CMS |
| Exelixis Inc. | $19.74 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218809456 | CMS |
| Genentech USA, Inc. | $32.27 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211613305 | CMS |
| GlaxoSmithKline, LLC. | $19.55 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190571236 | CMS |
| Janssen Biotech, Inc. | $20.15 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174581294 | CMS |
| Janssen Biotech, Inc. | $19.58 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174581356 | CMS |
| Merck Sharp & Dohme LLC | $24.58 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238026994 | CMS |
| PharmaEssentia USA Corporation | $31.63 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246832077 | CMS |
| SOBI, INC | $22.58 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240281901 | CMS |
| Surmodics, Inc. | $17.99 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1209906381 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.25 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224020679 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.